CardioKinetix

The Company, based in Menlo Park, CA, has developed a novel transcatheter implant called the Parachute® Ventricular Partitioning Device (Parachute). The Parachute intends to treat heart failure resulting from a heart attack in patients worldwide by improving overall cardiac function.
Type
Private
HQ
Menlo Park, US
Founded
2003
Employees
41 (est)-2%
CardioKinetix was founded in 2003 and is headquartered in Menlo Park, US

Key People at CardioKinetix

Maria Sainz

Maria Sainz

President & CEO & Board Director
Brett Hale

Brett Hale

CFO
Jodie Fam

Jodie Fam

VP - Europe
Bob Nicholas

Bob Nicholas

VP, Operations
Jennifer Mateus

Jennifer Mateus

VP, Regulatory Affairs & Quality Assurance
Thomas M. Engels

Thomas M. Engels

VP, Clinical Affairs

CardioKinetix Locations

Menlo Park, US

CardioKinetix Metrics

CardioKinetix Summary

Founding Date

2003

Total Funding

$136 M

Latest funding size

$50 M

Time since last funding

almost 2 years

Investors

CardioKinetix's latest funding round of $50 M was in December 2014. In total, CardioKinetix has raised $136 M.

CardioKinetix Company Life